| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kozarich John W is a Director at LGND, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 57 sales. Those positions are worth an estimated $14.7M at current prices.
Our model assigns Kozarich John W a middling insider score of 55/100, based on 10 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.2%.
Kozarich John W's largest disclosed position is in LGND as Director, worth about $12.8M. The recent filings there lean toward selling, a net 46,328 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 2,500 | $112.92 | $282,300.00 | -8.9% | |
| Oct 1, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $275.04 | $687,610.00 | -8.7% | |
| Jul 2, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $207.48 | $518,699.25 | -8.0% | |
| Apr 2, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $160.43 | $401,062.50 | -7.5% | |
| Jan 10, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $145.00 | $362,500.00 | -7.0% | |
| Nov 16, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 5,000 | $141.71 | $708,550.00 | -12.3% | |
| Sep 7, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $115.00 | $115,000.00 | -2.4% | |
| Sep 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,666 | $105.40 | $175,596.80 | -1.0% | |
| Aug 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $137.57 | $137,569.00 | -0.6% | |
| Jul 1, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 1,000 | $121.40 | $121,402.00 | -0.8% |